Watch our YouTube channel   Find us on Facebook    Find us on Instagram

We are now offering consultations and courses at our Auckland clinic. Online consultations/courses are available for those unable to attend the clinic. Please phone or email our clinic to arrange a time, or book online.


  • As easy as drawing breath
    I was gratified to read John Roughan’s article in the New Zealand Herald 9 October and learn that a tip he learned on the Buteyko course he did back in 2006 has helped relieve his sleep apnoea. Unfortunately most people are unaware that snoring and sleep apnoea may be the result of a faulty breathing pattern and that learning a breathing technique like Buteyko can help resolve the problem. More
    Posted: Sunday 7 November 2010
  • NYC Radio WBAI interview with Dr Robert Cowie
    Dr Robert Cowie, from the University of Calgary, Canada and a world authority on asthma, authored one of the largest randomised controlled trials of the Buteyko technique. The trial is published in Respiratory Medicine 2008; 102:726-32. More
    Posted: Thursday 21 October 2010
  • My job:  Helping others to breathe easy
    Article on Glenn White by Donna McIntyre in NZ Herald More
    Posted: Tuesday 21 September 2010
  • A Breathing Technique Offers Help for People With Asthma
    Jane E. Brody of the New York Times writes about witnessing the 'miraculous' transformation in her friend's asthma after learning the Buteyko method. To read the full article go to the New York Times website: More
    Posted: Monday 2 November 2009
  • Nurses to be trained to teach Buteyko Breathing Technique to asthmatics
    A new course to train nurses how to teach the Buteyko Breathing Technique to people with asthma has been launched by Coventry University and the Buteyko Breathing Association. More
    Posted: Monday 6 April 2009
  • FDA Panel Votes to Ban Asthma Drugs
    New York Times article: ROCKVILLE, Md. - A panel of federal drug experts voted on Thursday that the drugs Serevent and Foradil should be banned from use in the treatment of asthma, but the experts said that Advair and Symbicort, which together are far more popular, should continue to be used. More
    Posted: Thursday 11 December 2008
  • FDA Panel decides asthma drugs - Serevent and Oxis - aren’t worth the risk
    An FDA Panel said Thursday that the risks of death and serious injury associated with two popular brands of asthma inhalers are greater than the benefits of the drugs. However, in what is sure to be a controversial opinion, the panel said that Advair (Symbicort) should continue to be used to treat asthma. More
    Posted: Thursday 11 December 2008

«Prev 1 2 3

View News index »

Helping people with breathing disorders since 2001

20 Arthur Street, Freemans Bay, Auckland 1011, New Zealand  |  Phone +64 9 360 6291  |  Email

Download our leaflets [PDFs]:  Do you suffer from asthma or allergies? »    Do you snore or suffer from sleep apnoea? »

BIBH logo
Registered Practitioner / Practitioner Trainer

All cartoons courtesy of Chris Slane, Qantas Media Awards Cartoonist of the Year 2010  ©

Site design © 2015